In Vitro Activity of Ceftibuten/VNRX-5236 against Urinary Tract Infection Isolates of Antimicrobial-Resistant Enterobacterales

Ceftibuten/VNRX-7145 is a cephalosporin/boronate β-lactamase inhibitor combination under development as an oral treatment for complicated urinary tract infections caused by Enterobacterales producing serine β-lactamases (Ambler class A, C, and D). In vivo, VNRX-7145 (VNRX-5236 etzadroxil) is cleaved...

Descripción completa

Detalles Bibliográficos
Autores principales: Karlowsky, James A., Hackel, Meredith A., Sahm, Daniel F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Susceptibility
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765315/
https://www.ncbi.nlm.nih.gov/pubmed/34662183
http://dx.doi.org/10.1128/AAC.01304-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765315/
https://www.ncbi.nlm.nih.gov/pubmed/34662183
http://dx.doi.org/10.1128/AAC.01304-21

Ejemplares similares